Surface-engineered dual drug-loaded tumor-targeted liposomal nanoparticles to overcome the therapeutic resistance in glioblastoma multiforme
Debabrata Mukhopadhyay(Jacksonville College), Alfredo Quiñones‐Hinojosa(Jacksonville College), Ramcharan Singh Angom(Mayo Clinic in Arizona), Naga Malleswara Rao Nakka(Jacksonville College), Beatriz I Fernandez Gil(WinnMed), Enfeng Wang(Jacksonville College), Tanmay Kulkarni(WinnMed), Krishnendu Pal(Jacksonville College), Hari Krishnareddy Rachamalla(Indian Institute of Chemical Technology), Paola Suárez-Meade(WinnMed), Santanu Bhattacharya(Indian Association for the Cultivation of Science), Vijay Sagar Madamsetty(Jacksonville College)
Cited by 0
Related Papers
c-Met signaling induces a reprogramming network and supports the glioblastoma stem-like phenotype
|Proceedings of the National Academy of Sciences|2011|261
In vivo gene delivery mediated by non-viral vectors for cancer therapy
|Journal of Controlled Release|2020|240
Recent Trends of the Bio-Inspired Nanoparticles in Cancer Theranostics
|Frontiers in Pharmacology|2019|210
Dexamethasone: Insights into Pharmacological Aspects, Therapeutic Mechanisms, and Delivery Systems
|ACS Biomaterials Science & Engineering|2022|174
Activation of Sp1-mediated Vascular Permeability Factor/Vascular Endothelial Growth Factor Transcription Requires Specific Interaction with Protein Kinase C ζ
|Journal of Biological Chemistry|1998|164